Lipid Nanoparticles Market by Product (Ionizable lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (siRNA, mRNA), Application, Service Type (Formulation Development, Manufacturing) - Global Forecast to 2029

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
• 1.4 YEARS CONSIDERED
• 1.5 CURRENCY CONSIDERED
  • 1.5.1 VALUE UNIT
• 1.6 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
• 2.2 MARKET ESTIMATION METHODOLOGY
  • 2.2.1 GLOBAL MARKET ESTIMATION
  • 2.2.2 INSIGHTS OF PRIMARY EXPERTS
• 2.3 MARKET GROWTH RATE PROJECTIONS
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 LNP RAW MATERIALS & SERVICES MARKET OVERVIEW
• 4.2 ASIA PACIFIC: LNP RAW MATERIALS & SERVICES MARKET, BY PRODUCT
• 4.3 LNP RAW MATERIALS & SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 LNP RAW MATERIALS MARKET, BY END USER, 2023
• 4.5 LNP SERVICES MARKET, BY END USER, 2023

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing use of lipid nanoparticles in anti-cancer research
    • 5.2.1.2 High uptake in RNA-based therapeutic research
    • 5.2.1.3 Growing government focus on R&D for LNP-based drugs
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Stringent regulatory requirements
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing demand for advanced drug delivery systems
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Challenges associated with LNP formulation
  • 5.2.5 INDUSTRY TRENDS
    • 5.2.5.1 Growing preference for personalized medicine and targeted drug delivery
    • 5.2.5.2 Advancements in mRNA-based vaccine technology
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 PRICING ANALYSIS
  • 5.4.1 INDICATIVE SELLING PRICE OF LNP PRODUCTS, BY KEY PLAYER
  • 5.4.2 INDICATIVE SELLING PRICE, BY PRODUCT
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
  • 5.7.1 LNP RAW MATERIALS & SERVICES MARKET: ROLE IN ECOSYSTEM
• 5.8 TECHNOLOGY ANALYSIS
  • 5.8.1 KEY TECHNOLOGIES
    • 5.8.1.1 Nanotechnology-based drug delivery
    • 5.8.1.2 Nucleic acid delivery
  • 5.8.2 COMPLEMENTARY TECHNOLOGIES
    • 5.8.2.1 Drug encapsulation techniques
    • 5.8.2.2 Surface modification and functionalization technologies
  • 5.8.3 ADJACENT TECHNOLOGIES
    • 5.8.3.1 Biotechnology & genetic engineering technologies
    • 5.8.3.2 Nanotechnology-based formulation techniques
• 5.9 PATENT ANALYSIS
  • 5.9.1 PATENTS FILED, BY DOCUMENT TYPE, 2014-2023
  • 5.9.2 INNOVATION AND PATENT APPLICATIONS
  • 5.9.3 TOP APPLICANTS
• 5.10 KEY CONFERENCES & EVENTS, 2024-2025
• 5.11 REGULATORY LANDSCAPE
  • 5.11.1 REGULATORY SCENARIO
  • 5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.12 PORTER'S FIVE FORCES ANALYSIS
  • 5.12.1 DEGREE OF COMPETITION
  • 5.12.2 BARGAINING POWER OF SUPPLIERS
  • 5.12.3 BARGAINING POWER OF BUYERS
  • 5.12.4 THREAT OF SUBSTITUTES
  • 5.12.5 THREAT OF NEW ENTRANTS
• 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.13.1 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR LIPID NANOPARTICLES: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
• 5.14 KEY BUYING CRITERIA
  • 5.14.1 BUYING CRITERIA FOR LNP RAW MATERIALS
  • 5.14.2 BUYING CRITERIA FOR LNP RAW MATERIALS, BY END USER
  • 5.14.3 BUYING CRITERIA FOR LNP SERVICES
  • 5.14.4 BUYING CRITERIA FOR LNP SERVICES, BY END USER
• 5.15 INVESTMENT & FUNDING SCENARIO
• 5.16 IMPACT OF GENERATIVE AI ON LNP RAW MATERIALS & SERVICES MARKET

6 LNP RAW MATERIALS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 IONIZABLE LIPIDS
  • 6.2.1 HIGH DEMAND FOR MRNA-BASED VACCINES TO PROPEL MARKET
• 6.3 PEGYLATED LIPIDS
  • 6.3.1 GROWING FOCUS ON NUCLEIC ACID MEDICINES TO BOOST DEMAND
• 6.4 NEUTRAL LIPIDS
  • 6.4.1 ENHANCED STABILITY AND HIGH UPTAKE IN THERAPEUTIC APPLICATIONS TO DRIVE MARKET
• 6.5 PHOSPHOLIPIDS
  • 6.5.1 BIOLOGICAL COMPATIBILITY AND CUSTOMIZATION FEATURES TO SUPPORT MARKET GROWTH
• 6.6 KITS & REAGENTS
  • 6.6.1 ADVANCEMENTS IN LNP FORMULATION TECHNIQUES TO DRIVE MARKET
• 6.7 OTHER FORMULATION MATERIALS

7 LNP RAW MATERIALS MARKET, BY LNP TYPE

• 7.1 INTRODUCTION
• 7.2 SOLID LIPID NANOPARTICLES (SLNS)
  • 7.2.1 ADVANTAGES OVER CONVENTIONAL DRUG CARRIERS TO DRIVE MARKET
• 7.3 NANOSTRUCTURED LIPID CARRIERS (NLCS)
  • 7.3.1 HIGH DRUG LOADING CAPACITY TO PROPEL MARKET
• 7.4 OTHER LNP TYPES

8 LNP RAW MATERIALS MARKET, BY MOLECULE TYPE

• 8.1 INTRODUCTION
• 8.2 SIRNA
  • 8.2.1 GROWING FOCUS ON TARGETED DRUG DELIVERY TO DRIVE MARKET
• 8.3 MRNA
  • 8.3.1 GROWING UPTAKE IN VACCINE DEVELOPMENT TO PROPEL MARKET
• 8.4 OTHER MOLECULES

9 LNP RAW MATERIALS MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 COMMERCIAL APPLICATIONS
  • 9.2.1 POLYNEUROPATHY
    • 9.2.1.1 Ability to provide targeted & sustained release of therapeutic agents to boost demand
  • 9.2.2 COVID-19
    • 9.2.2.1 Enhanced stability and distribution of mRNA to drive market
• 9.3 CLINICAL APPLICATIONS
  • 9.3.1 COVID-19
    • 9.3.1.1 Threat of evolving emerging variants to fuel uptake
  • 9.3.2 CANCER
    • 9.3.2.1 Increasing focus on oncology therapeutics to drive market
  • 9.3.3 OTHER CLINICAL APPLICATIONS

10 LNP RAW MATERIALS MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.2.1 INCREASING DRUG DEVELOPMENT ACTIVITIES TO FUEL MARKET
• 10.3 ACADEMIC & RESEARCH INSTITUTES
  • 10.3.1 HIGH FOCUS ON R&D FOR GENE THERAPY AND MEDICATION ADMINISTRATION TO DRIVE MARKET
• 10.4 CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS (CDMOS)
  • 10.4.1 GROWING OUTSOURCING OF LNP FORMULATION SERVICES TO PROPEL MARKET

11 LNP SERVICES MARKET, BY SERVICE TYPE

• 11.1 INTRODUCTION
• 11.2 FORMULATION DEVELOPMENT SERVICES
  • 11.2.1 GROWING FOCUS ON TARGETED & EFFECTIVE DRUG DELIVERY TO PROPEL MARKET
• 11.3 MANUFACTURING SERVICES
  • 11.3.1 RISING DEMAND FOR LIPID-BASED CARRIERS FOR GENE THERAPY AND VACCINE DEVELOPMENT TO DRIVE MARKET
• 11.4 OTHER SERVICES

12 LNP SERVICES MARKET, BY END USER

• 12.1 INTRODUCTION
• 12.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 12.2.1 DRUG DEVELOPMENT & COMMERCIALIZATION TO PROPEL MARKET
• 12.3 ACADEMIC & RESEARCH INSTITUTES
  • 12.3.1 ACCESS TO ADVANCED INFRASTRUCTURE AND SPECIALIZED EXPERTISE TO SUPPORT MARKET GROWTH

13 LNP RAW MATERIALS & SERVICES MARKET, BY REGION

• 13.1 INTRODUCTION
• 13.2 NORTH AMERICA
  • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 13.2.2 US
    • 13.2.2.1 High pharmaceutical R&D expenditure to drive market
  • 13.2.3 CANADA
    • 13.2.3.1 Growing focus on personalized medicine to drive market
• 13.3 EUROPE
  • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 13.3.2 GERMANY
    • 13.3.2.1 Rising development activities for LNP production to drive market
  • 13.3.3 UK
    • 13.3.3.1 Pioneering research programs for drug delivery systems to boost demand
  • 13.3.4 FRANCE
    • 13.3.4.1 Government funding for proteomics and genomics research to support market growth
  • 13.3.5 ITALY
    • 13.3.5.1 Growth in life sciences research to propel market
  • 13.3.6 SPAIN
    • 13.3.6.1 Growing demand for cancer therapeutics to drive market
  • 13.3.7 REST OF EUROPE
• 13.4 ASIA PACIFIC
  • 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 13.4.2 CHINA
    • 13.4.2.1 Low manufacturing costs and rising outsourcing of services to CDMOs to drive market
  • 13.4.3 JAPAN
    • 13.4.3.1 Demand for LNP-based mRNA vaccines to fuel market
  • 13.4.4 INDIA
    • 13.4.4.1 Growth in pharmaceutical industry to drive market
  • 13.4.5 SOUTH KOREA
    • 13.4.5.1 Rising number of clinical trials to boost demand
  • 13.4.6 AUSTRALIA
    • 13.4.6.1 Growing requirement for innovative drug delivery systems to propel market
  • 13.4.7 REST OF ASIA PACIFIC
• 13.5 LATIN AMERICA
  • 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 13.5.2 BRAZIL
    • 13.5.2.1 Global manufacturing hub for pharmaceutical drugs to fuel uptake
  • 13.5.3 MEXICO
    • 13.5.3.1 Large target patient population and demand for novel drug delivery technology to drive market
  • 13.5.4 REST OF LATIN AMERICA
• 13.6 MIDDLE EAST
  • 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
  • 13.6.2 GCC COUNTRIES
    • 13.6.2.1 Economic & healthcare expansion to support market growth
  • 13.6.3 REST OF MIDDLE EAST
• 13.7 AFRICA
  • 13.7.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
  • 13.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

14 COMPETITIVE LANDSCAPE

• 14.1 INTRODUCTION
• 14.2 KEY PLAYER STRATEGY/RIGHT TO WIN
• 14.3 REVENUE ANALYSIS
• 14.4 MARKET SHARE ANALYSIS
  • 14.4.1 LNP SERVICES MARKET
• 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 14.5.1 STARS
  • 14.5.2 EMERGING LEADERS
  • 14.5.3 PERVASIVE PLAYERS
  • 14.5.4 PARTICIPANTS
  • 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 14.5.5.1 Company footprint
    • 14.5.5.2 Product footprint
    • 14.5.5.3 Application footprint
    • 14.5.5.4 Service type footprint
    • 14.5.5.5 Region footprint
• 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 14.6.1 PROGRESSIVE COMPANIES
  • 14.6.2 RESPONSIVE COMPANIES
  • 14.6.3 DYNAMIC COMPANIES
  • 14.6.4 STARTING BLOCKS
  • 14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 14.7 COMPANY VALUATION & FINANCIAL METRICS
  • 14.7.1 FINANCIAL METRICS
  • 14.7.2 COMPANY VALUATION
• 14.8 BRAND/PRODUCT COMPARISON ANALYSIS
• 14.9 COMPETITIVE SCENARIO
  • 14.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
  • 14.9.2 DEALS
  • 14.9.3 EXPANSIONS

15 COMPANY PROFILES

• 15.1 KEY PLAYERS
  • 15.1.1 AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC)
    • 15.1.1.1 Business overview
    • 15.1.1.2 Products/Services offered
    • 15.1.1.3 Recent developments
      • 15.1.1.3.1 Deals
    • 15.1.1.4 MnM view
      • 15.1.1.4.1 Key strengths
      • 15.1.1.4.2 Strategic choices
      • 15.1.1.4.3 Weaknesses & competitive threats
  • 15.1.2 MERCK KGAA
    • 15.1.2.1 Business overview
    • 15.1.2.2 Products/Services offered
    • 15.1.2.3 Recent developments
      • 15.1.2.3.1 Deals
      • 15.1.2.3.2 Expansions
    • 15.1.2.4 MnM view
      • 15.1.2.4.1 Key strengths
      • 15.1.2.4.2 Strategic choices
      • 15.1.2.4.3 Weaknesses & competitive threats
  • 15.1.3 EVONIK INDUSTRIES AG
    • 15.1.3.1 Business overview
    • 15.1.3.2 Products/Services offered
    • 15.1.3.3 Recent developments
      • 15.1.3.3.1 Deals
    • 15.1.3.4 MnM view
      • 15.1.3.4.1 Key strengths
      • 15.1.3.4.2 Strategic choices
      • 15.1.3.4.3 Weaknesses & competitive threats
  • 15.1.4 NIPPON FINE CHEMICAL
    • 15.1.4.1 Business overview
    • 15.1.4.2 Products/Services offered
    • 15.1.4.3 MnM view
      • 15.1.4.3.1 Key strengths
      • 15.1.4.3.2 Strategic choices
      • 15.1.4.3.3 Weaknesses & competitive threats
  • 15.1.5 NOF CORPORATION
    • 15.1.5.1 Business overview
    • 15.1.5.2 Products/Services offered
    • 15.1.5.3 Recent developments
      • 15.1.5.3.1 Deals
    • 15.1.5.4 MnM view
      • 15.1.5.4.1 Key strengths
      • 15.1.5.4.2 Strategic choices
      • 15.1.5.4.3 Weaknesses & competitive threats
  • 15.1.6 FUJIFILM PHARMACEUTICALS U.S.A., INC. (FUJIFILM HOLDINGS CORPORATION)
    • 15.1.6.1 Business overview
    • 15.1.6.2 Products/Services offered
    • 15.1.6.3 Recent developments
      • 15.1.6.3.1 Expansions
  • 15.1.7 PRECISION NANOSYSTEMS (CYTIVA)
    • 15.1.7.1 Business overview
    • 15.1.7.2 Products/Services offered
    • 15.1.7.3 Recent developments
      • 15.1.7.3.1 Product/Service launches
      • 15.1.7.3.2 Deals
      • 15.1.7.3.3 Expansions
  • 15.1.8 RECIPHARM AB
    • 15.1.8.1 Business overview
    • 15.1.8.2 Products/Services offered
    • 15.1.8.3 Recent developments
      • 15.1.8.3.1 Deals
  • 15.1.9 EMERGENT
    • 15.1.9.1 Business overview
    • 15.1.9.2 Products/Services offered
    • 15.1.9.3 Recent developments
      • 15.1.9.3.1 Deals
  • 15.1.10 EUROAPI
    • 15.1.10.1 Business overview
    • 15.1.10.2 Products/Services offered
  • 15.1.11 CAYMAN CHEMICAL
    • 15.1.11.1 Business overview
    • 15.1.11.2 Products/Services offered
  • 15.1.12 CORDENPHARMA
    • 15.1.12.1 Business overview
    • 15.1.12.2 Products/Services offered
    • 15.1.12.3 Recent developments
      • 15.1.12.3.1 Product/Service launches
      • 15.1.12.3.2 Deals
      • 15.1.12.3.3 Expansions
  • 15.1.13 GATTEFOSSE
    • 15.1.13.1 Business overview
    • 15.1.13.2 Products/Services offered
  • 15.1.14 ACUITAS THERAPEUTICS
    • 15.1.14.1 Business overview
    • 15.1.14.2 Products/Services offered
    • 15.1.14.3 Recent developments
      • 15.1.14.3.1 Deals
  • 15.1.15 IOI OLEO GMBH
    • 15.1.15.1 Business overview
    • 15.1.15.2 Products/Services offered
• 15.2 OTHER PLAYERS
  • 15.2.1 CREATIVE BIOLABS
  • 15.2.2 CURAPATH
  • 15.2.3 LIPOID GMBH
  • 15.2.4 NANOCS INC.
  • 15.2.5 MEDKOO BIOSCIENCES, INC.
  • 15.2.6 POLYSCIENCES INC.
  • 15.2.7 BIOVECTRA
  • 15.2.8 ASCENDIA PHARMACEUTICALS
  • 15.2.9 CURIA GLOBAL, INC.
  • 15.2.10 VERNAL BIOSCIENCES

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS

List of Tables

• TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
• TABLE 2 RISK ANALYSIS
• TABLE 3 LNP RAW MATERIALS & SERVICES MARKET: IMPACT ANALYSIS
• TABLE 4 INDICATIVE PRICING OF LNP PRODUCTS, BY KEY PLAYER
• TABLE 5 INDICATIVE PRICING OF LNP PRODUCTS, BY TYPE
• TABLE 6 PATENTS FILED, 2014-2023
• TABLE 7 INDICATIVE LIST OF PATENTS IN LNP RAW MATERIALS & SERVICES MARKET
• TABLE 8 LNP RAW MATERIALS & SERVICES MARKET: LIST OF CONFERENCES & EVENTS (2024-2025)
• TABLE 9 REGULATORY SCENARIO
• TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 13 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 14 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 15 LNP RAW MATERIALS & SERVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 16 BUYING CRITERIA FOR LNP RAW MATERIALS, BY END USER
• TABLE 17 LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 18 IONIZABLE LIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 19 NORTH AMERICA: IONIZABLE LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 20 EUROPE: IONIZABLE LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 21 ASIA PACIFIC: IONIZABLE LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 22 LATIN AMERICA: IONIZABLE LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 23 MIDDLE EAST: IONIZABLE LIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 24 PEGYLATED LIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 25 NEUTRAL LIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 26 NORTH AMERICA: NEUTRAL LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 27 EUROPE: NEUTRAL LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 28 ASIA PACIFIC: NEUTRAL LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 29 LATIN AMERICA: NEUTRAL LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 30 MIDDLE EAST: NEUTRAL LIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 31 PHOSPHOLIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 32 NORTH AMERICA: PHOSPHOLIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 33 EUROPE: PHOSPHOLIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 34 ASIA PACIFIC: PHOSPHOLIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 35 LATIN AMERICA: PHOSPHOLIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 36 MIDDLE EAST: PHOSPHOLIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 37 KITS & REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 38 OTHER FORMULATION MATERIALS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 39 LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 40 SOLID LIPID NANOPARTICLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 41 NORTH AMERICA: SOLID LIPID NANOPARTICLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 42 EUROPE: SOLID LIPID NANOPARTICLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 43 ASIA PACIFIC: SOLID LIPID NANOPARTICLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 44 LATIN AMERICA: SOLID LIPID NANOPARTICLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 45 MIDDLE EAST: SOLID LIPID NANOPARTICLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 46 NANOSTRUCTURED LIPID CARRIERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 47 NORTH AMERICA: NANOSTRUCTURED LIPID CARRIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 48 EUROPE: NANOSTRUCTURED LIPID CARRIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 49 ASIA PACIFIC: NANOSTRUCTURED LIPID CARRIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 50 LATIN AMERICA: NANOSTRUCTURED LIPID CARRIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 51 MIDDLE EAST: NANOSTRUCTURED LIPID CARRIERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 52 OTHER LNP TYPES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 53 NORTH AMERICA: OTHER LNP TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 54 EUROPE: OTHER LNP TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 55 ASIA PACIFIC: OTHER LNP TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 56 LATIN AMERICA: OTHER LNP TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 57 MIDDLE EAST: OTHER LNP TYPES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 58 LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 59 LNP RAW MATERIALS MARKET FOR SIRNA, BY REGION, 2022-2029 (USD MILLION)
• TABLE 60 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR SIRNA, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 61 EUROPE: LNP RAW MATERIALS MARKET FOR SIRNA, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 62 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR SIRNA, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 63 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR SIRNA, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 64 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR SIRNA, BY REGION, 2022-2029 (USD MILLION)
• TABLE 65 LNP RAW MATERIALS MARKET FOR MRNA, BY REGION, 2022-2029 (USD MILLION)
• TABLE 66 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR MRNA, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 67 EUROPE: LNP RAW MATERIALS MARKET FOR MRNA, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 68 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR MRNA, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 69 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR MRNA, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 70 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR MRNA, BY REGION, 2022-2029 (USD MILLION)
• TABLE 71 LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 72 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 73 EUROPE: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 74 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 75 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 76 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 77 LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 78 LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 79 LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 80 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 81 EUROPE: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 82 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 83 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 84 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 85 LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY REGION, 2022-2029 (USD MILLION)
• TABLE 86 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 87 EUROPE: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 88 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 89 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 90 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY REGION, 2022-2029 (USD MILLION)
• TABLE 91 LNP RAW MATERIALS MARKET FOR COVID-19 (COMMERCIAL APPLICATIONS), BY REGION, 2022-2029 (USD MILLION)
• TABLE 92 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR COVID-19 (COMMERCIAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 93 EUROPE: LNP RAW MATERIALS MARKET FOR COVID-19 (COMMERCIAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 94 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COVID-19 (COMMERCIAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 95 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COVID-19 (COMMERCIAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 96 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COVID-19 (COMMERCIAL APPLICATIONS), BY REGION, 2022-2029 (USD MILLION)
• TABLE 97 LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 98 LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 99 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 100 EUROPE: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 101 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 102 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 103 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 104 LNP RAW MATERIALS MARKET FOR COVID-19 (CLINICAL APPLICATIONS), BY REGION, 2022-2029 (USD MILLION)
• TABLE 105 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR COVID-19 (CLINICAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 106 EUROPE: LNP RAW MATERIALS MARKET FOR COVID-19 (CLINICAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 107 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COVID-19 (CLINICAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 108 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COVID-19 (CLINICAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 109 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COVID-19 (CLINICAL APPLICATIONS), BY REGION, 2022-2029 (USD MILLION)
• TABLE 110 LNP RAW MATERIALS MARKET FOR CANCER, BY REGION, 2022-2029 (USD MILLION)
• TABLE 111 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 112 EUROPE: LNP RAW MATERIALS MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 113 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 114 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 115 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CANCER, BY REGION, 2022-2029 (USD MILLION)
• TABLE 116 LNP RAW MATERIALS MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 117 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 118 EUROPE: LNP RAW MATERIALS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 119 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 120 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 121 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR OTHER DISEASES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 122 LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 123 LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 124 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 125 EUROPE: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 126 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 127 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 128 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 129 LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 130 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 131 EUROPE: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 132 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 133 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 134 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 135 LNP RAW MATERIALS MARKET FOR CDMOS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 136 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 137 EUROPE: LNP RAW MATERIALS MARKET FOR CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 138 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 139 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 140 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CDMOS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 141 LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 142 FORMULATION DEVELOPMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 143 MANUFACTURING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 144 OTHER SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 145 LNP SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 146 LNP SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 147 LNP SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 148 LNP RAW MATERIALS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 149 LNP SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 150 NORTH AMERICA: LNP RAW MATERIALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 151 NORTH AMERICA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 152 NORTH AMERICA: LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 153 NORTH AMERICA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 154 NORTH AMERICA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 155 NORTH AMERICA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 156 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 157 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 158 NORTH AMERICA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 159 NORTH AMERICA: LNP SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 160 US: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 161 US: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 162 US: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 163 US: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 164 US: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 165 US: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 166 US: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 167 CANADA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 168 CANADA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 169 CANADA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 170 CANADA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 171 CANADA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 172 CANADA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 173 CANADA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 174 EUROPE: LNP RAW MATERIALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 175 EUROPE: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 176 EUROPE: LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 177 EUROPE: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 178 EUROPE: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 179 EUROPE: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 180 EUROPE: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 181 EUROPE: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 182 EUROPE: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 183 EUROPE: LNP SERVICES MARKET BY END USER, 2022-2029 (USD MILLION)
• TABLE 184 GERMANY: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 185 GERMANY: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 186 GERMANY: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 187 GERMANY: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 188 GERMANY: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 189 GERMANY: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 190 GERMANY: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 191 UK: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 192 UK: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 193 UK: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 194 UK: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 195 UK: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 196 UK: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 197 UK: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 198 FRANCE: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 199 FRANCE: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 200 FRANCE: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 201 FRANCE: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 202 FRANCE: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 203 FRANCE: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 204 FRANCE: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 205 ITALY: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 206 ITALY: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 207 ITALY: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 208 ITALY: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 209 ITALY: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 210 ITALY: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 211 ITALY: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 212 SPAIN: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 213 SPAIN: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 214 SPAIN: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 215 SPAIN: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 216 SPAIN: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 217 SPAIN: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 218 SPAIN: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 219 REST OF EUROPE: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 220 REST OF EUROPE: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 221 REST OF EUROPE: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 222 REST OF EUROPE: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 223 REST OF EUROPE: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 224 REST OF EUROPE: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 225 REST OF EUROPE: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 226 ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 227 ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 228 ASIA PACIFIC: LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 229 ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 230 ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 231 ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 232 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 233 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 234 ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 235 ASIA PACIFIC: LNP SERVICES MARKET BY END USER, 2022-2029 (USD MILLION)
• TABLE 236 CHINA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 237 CHINA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 238 CHINA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 239 CHINA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 240 CHINA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 241 CHINA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 242 CHINA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 243 JAPAN: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 244 JAPAN: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 245 JAPAN: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 246 JAPAN: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 247 JAPAN: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 248 JAPAN: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 249 JAPAN: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 250 INDIA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 251 INDIA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 252 INDIA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 253 INDIA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 254 INDIA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 255 INDIA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 256 INDIA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 257 SOUTH KOREA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 258 SOUTH KOREA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 259 SOUTH KOREA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 260 SOUTH KOREA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 261 SOUTH KOREA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 262 SOUTH KOREA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 263 SOUTH KOREA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 264 AUSTRALIA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 265 AUSTRALIA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 266 AUSTRALIA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 267 AUSTRALIA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 268 AUSTRALIA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE,2022-2029 (USD MILLION)
• TABLE 269 AUSTRALIA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 270 AUSTRALIA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 271 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 272 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 273 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 274 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 275 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 276 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 277 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 278 LATIN AMERICA: LNP RAW MATERIALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 279 LATIN AMERICA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 280 LATIN AMERICA: LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 281 LATIN AMERICA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 282 LATIN AMERICA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 283 LATIN AMERICA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 284 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 285 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 286 LATIN AMERICA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 287 LATIN AMERICA: LNP SERVICES MARKET BY END USER, 2022-2029 (USD MILLION)
• TABLE 288 BRAZIL: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 289 BRAZIL: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 290 BRAZIL: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 291 BRAZIL: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 292 BRAZIL: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 293 BRAZIL: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 294 BRAZIL: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 295 MEXICO: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 296 MEXICO: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 297 MEXICO: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 298 MEXICO: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 299 MEXICO: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 300 MEXICO: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 301 MEXICO: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 302 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 303 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 304 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 305 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 306 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 307 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 308 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 309 MIDDLE EAST: LNP RAW MATERIALS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 310 MIDDLE EAST: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 311 MIDDLE EAST: LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 312 MIDDLE EAST: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 313 MIDDLE EAST: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 314 MIDDLE EAST: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 315 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 316 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 317 MIDDLE EAST: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 318 MIDDLE EAST: LNP SERVICES MARKET BY END USER, 2022-2029 (USD MILLION)
• TABLE 319 GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 320 GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 321 GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 322 GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 323 GCC COUNTRIES: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE,2022-2029 (USD MILLION)
• TABLE 324 GCC COUNTRIES: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 325 GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 326 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 327 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 328 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 329 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 330 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE,2022-2029 (USD MILLION)
• TABLE 331 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 332 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 333 AFRICA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 334 AFRICA: LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 335 AFRICA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
• TABLE 336 AFRICA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
• TABLE 337 AFRICA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 338 AFRICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 339 AFRICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 340 AFRICA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 341 AFRICA: LNP SERVICES MARKET BY END USER, 2022-2029 (USD MILLION)
• TABLE 342 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
• TABLE 343 LNP RAW MATERIALS MARKET: DEGREE OF COMPETITION
• TABLE 344 LNP SERVICES MARKET: TOP SERVICE PROVIDERS (2023)
• TABLE 345 LNP RAW MATERIALS & SERVICES MARKET: PRODUCT FOOTPRINT
• TABLE 346 LNP RAW MATERIALS & SERVICES MARKET: APPLICATION FOOTPRINT
• TABLE 347 LNP RAW MATERIALS & SERVICES MARKET: SERVICE TYPE FOOTPRINT
• TABLE 348 LNP RAW MATERIALS & SERVICES MARKET: REGION FOOTPRINT
• TABLE 349 LNP RAW MATERIALS & SERVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
• TABLE 350 LNP RAW MATERIALS & SERVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
• TABLE 351 LNP RAW MATERIALS & SERVICES MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-JUNE 2024
• TABLE 352 LNP RAW MATERIALS & SERVICES MARKET: DEALS, JANUARY 2021-JUNE 2024
• TABLE 353 LNP RAW MATERIALS & SERVICES MARKET: EXPANSIONS, JANUARY 2021-JUNE 2024
• TABLE 354 AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): COMPANY OVERVIEW
• TABLE 355 AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): PRODUCTS/SERVICES OFFERED
• TABLE 356 AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): DEALS, JANUARY 2021-JUNE 2024
• TABLE 357 MERCK KGAA: COMPANY OVERVIEW
• TABLE 358 MERCK KGAA: PRODUCTS/SERVICES OFFERED
• TABLE 359 MERCK KGAA: DEALS, JANUARY 2021-JUNE 2024
• TABLE 360 MERCK KGAA: EXPANSIONS, JANUARY 2021-JUNE 2024
• TABLE 361 EVONIK INDUSTRIES AG: COMPANY OVERVIEW
• TABLE 362 EVONIK INDUSTRIES AG: PRODUCTS/SERVICES OFFERED
• TABLE 363 EVONIK INDUSTRIES AG: DEALS, JANUARY 2021-JUNE 2024
• TABLE 364 NIPPON FINE CHEMICAL CO., LTD.: COMPANY OVERVIEW
• TABLE 365 NIPPON FINE CHEMICAL CO., LTD.: PRODUCTS/SERVICES OFFERED
• TABLE 366 NOF CORPORATION: COMPANY OVERVIEW
• TABLE 367 NOF CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 368 NOF CORPORATION: DEALS, JANUARY 2021-JUNE 2024
• TABLE 369 FUJIFILM PHARMACEUTICALS U.S.A., INC.: COMPANY OVERVIEW
• TABLE 370 FUJIFILM PHARMACEUTICALS U.S.A., INC.: PRODUCTS/SERVICES OFFERED
• TABLE 371 FUJIFILM PHARMACEUTICALS U.S.A., INC.: EXPANSIONS, JANUARY 2021-JUNE 2024
• TABLE 372 PRECISION NANOSYSTEMS: COMPANY OVERVIEW
• TABLE 373 PRECISION NANOSYSTEMS: PRODUCTS/SERVICES OFFERED
• TABLE 374 PRECISION NANOSYSTEMS: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JUNE 2024
• TABLE 375 PRECISION NANOSYSTEMS: DEALS, JANUARY 2021-JUNE 2024
• TABLE 376 PRECISION NANOSYSTEMS: EXPANSIONS, JANUARY 2021-JUNE 2024
• TABLE 377 RECIPHARM AB: COMPANY OVERVIEW
• TABLE 378 RECIPHARM AB: PRODUCTS/SERVICES OFFERED
• TABLE 379 RECIPHARM AB: DEALS, JANUARY 2021-JUNE 2024
• TABLE 380 EMERGENT: COMPANY OVERVIEW
• TABLE 381 EMERGENT: PRODUCTS/SERVICES OFFERED
• TABLE 382 EMERGENT: DEALS, JANUARY 2021-JUNE 2024
• TABLE 383 EUROAPI: COMPANY OVERVIEW
• TABLE 384 EUROAPI: PRODUCTS/SERVICES OFFERED
• TABLE 385 CAYMAN CHEMICAL: COMPANY OVERVIEW
• TABLE 386 CAYMAN CHEMICAL: PRODUCTS/SERVICES OFFERED
• TABLE 387 CORDENPHARMA: COMPANY OVERVIEW
• TABLE 388 CORDENPHARMA: PRODUCTS/SERVICES OFFERED
• TABLE 389 CORDENPHARMA: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JUNE 2024
• TABLE 390 CORDENPHARMA: DEALS, JANUARY 2021-JUNE 2024
• TABLE 391 CORDENPHARMA: EXPANSIONS, JANUARY 2021-JUNE 2024
• TABLE 392 GATTEFOSSE: COMPANY OVERVIEW
• TABLE 393 GATTEFOSSE: PRODUCTS/SERVICES OFFERED
• TABLE 394 ACUITAS THERAPEUTICS: COMPANY OVERVIEW
• TABLE 395 ACUITAS THERAPEUTICS: PRODUCTS/SERVICES OFFERED
• TABLE 396 ACUITAS THERAPEUTICS: DEALS, JANUARY 2021-JUNE 2024
• TABLE 397 IOI OLEO GMBH: COMPANY OVERVIEW
• TABLE 398 IOI OLEO GMBH: PRODUCTS/SERVICES OFFERED

List of Figures

• FIGURE 1 RESEARCH DESIGN
• FIGURE 2 LNP RAW MATERIALS & SERVICES MARKET: BREAKDOWN OF PRIMARIES
• FIGURE 3 LNP RAW MATERIALS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
• FIGURE 4 LNP SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
• FIGURE 5 MARKET SIZE ESTIMATION (RAW MATERIALS): APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
• FIGURE 6 MARKET SIZE ESTIMATION (SERVICES): APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
• FIGURE 7 ILLUSTRATIVE EXAMPLE OF NOF CORPORATION: REVENUE SHARE ANALYSIS (2023)
• FIGURE 8 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
• FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
• FIGURE 10 LNP RAW MATERIALS MARKET (SUPPLY SIDE): CAGR PROJECTIONS
• FIGURE 11 LNP SERVICES MARKET (SUPPLY SIDE): CAGR PROJECTIONS
• FIGURE 12 DATA TRIANGULATION METHODOLOGY
• FIGURE 13 LNP RAW MATERIALS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
• FIGURE 14 LNP RAW MATERIALS MARKET, BY LNP TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 15 LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 16 LNP RAW MATERIALS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 17 LNP RAW MATERIALS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 18 LNP SERVICES MARKET, BY SERVICE TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 19 LNP SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 20 LNP RAW MATERIALS & SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• FIGURE 21 INCREASING USE OF LIPID NANOPARTICLES IN RNA-BASED THERAPIES TO PROPEL LNP RAW MATERIALS MARKET
• FIGURE 22 IONIZABLE LIPIDS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
• FIGURE 23 JAPAN IS EXPECTED TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
• FIGURE 24 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 25 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 26 LNP RAW MATERIALS & SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 27 REVENUE SHIFT AND NEW REVENUE POCKETS FOR LNP RAW MATERIAL MANUFACTURERS
• FIGURE 28 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES
• FIGURE 29 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
• FIGURE 30 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING FORMULATION DEVELOPMENT & MANUFACTURING PHASE
• FIGURE 31 LNP RAW MATERIALS & SERVICES MARKET: ECOSYSTEM ANALYSIS
• FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR LIPID NANOPARTICLE PATENTS (JANUARY 2014-DECEMBER 2023)
• FIGURE 33 LNP RAW MATERIALS & SERVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 34 NORTH AMERICA: LNP RAW MATERIALS MARKET SNAPSHOT
• FIGURE 35 ASIA PACIFIC: LNP RAW MATERIALS MARKET SNAPSHOT
• FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN LNP RAW MATERIALS MARKET, 2019-2023 (USD MILLION)
• FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN LNP RAW MATERIALS MARKET (2023)
• FIGURE 38 LNP RAW MATERIALS & SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
• FIGURE 39 LNP RAW MATERIALS & SERVICES MARKET: COMPANY FOOTPRINT
• FIGURE 40 LNP RAW MATERIALS & SERVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
• FIGURE 41 EV/EBITDA OF KEY VENDORS
• FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 43 LNP RAW MATERIALS & SERVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
• FIGURE 44 AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): COMPANY SNAPSHOT (2023)
• FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2023)
• FIGURE 46 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT (2023)
• FIGURE 47 NIPPON FINE CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2023)
• FIGURE 48 NOF CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 49 FUJIFILM PHARMACEUTICALS U.S.A., INC.: COMPANY SNAPSHOT (2023)
• FIGURE 50 RECIPHARM AB: COMPANY SNAPSHOT (2023)
• FIGURE 51 EMERGENT: COMPANY SNAPSHOT (2023)
• FIGURE 52 EUROAPI: COMPANY SNAPSHOT (2023)
• FIGURE 53 IOI OLEO GMBH: COMPANY SNAPSHOT (2023)